Maryland 2023 Regular Session

Maryland Senate Bill SB647 Latest Draft

Bill / Engrossed Version Filed 04/04/2023

                             
 
EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. 
        [Brackets] indicate matter deleted from existing law. 
         Underlining indicates amendments to bill. 
         Strike out indicates matter stricken from the bill by amendment or deleted from the law by 
amendment. 
          *sb0647*  
  
SENATE BILL 647 
J2 	EMERGENCY BILL 	3lr1402 
    	CF HB 693 
By: Senators Carozza, Lam, Mautz, and Lewis Young 
Introduced and read first time: February 6, 2023 
Assigned to: Finance 
Committee Report: Favorable with amendments 
Senate action: Adopted 
Read second time: March 22, 2023 
 
CHAPTER ______ 
 
AN ACT concerning 1 
 
State Board of Pharmacy – Board Membership and, Delegated Pharmacy Acts, 2 
and Sunset Extension 3 
 
FOR the purpose of altering the membership of the State Board of Pharmacy to include a 4 
registered pharmacy technician; authorizing a licensed pharmacist, under certain 5 
circumstances, to delegate pharmacy acts the entry of certain data into databases 6 
or patient charts to be performed at a remote location to a registered pharmacy 7 
technician and a registered pharmacy intern; repealing the prohibition on a 8 
registered pharmacy technician administering influenza vaccines; prohibiting 9 
registered pharmacy technicians and pharmacy technician trainees from making 10 
decisions that require the professional judgment of a pharmacist; prohibiting a 11 
registered pharmacy technician from administering a vaccination except under 12 
certain circumstances; continuing the Board in accordance with the provisions of 13 
the Maryland Program Evaluation Act (sunset law) by extending to a certain date 14 
the termination provisions relating to certain statutory and regulatory authority of 15 
the Board; and generally relating to the State Board of Pharmacy. 16 
 
BY repealing and reenacting, without amendments, 17 
 Article – Health Occupations 18 
 Section 12–101(a) and 12–307(d)  19 
 Annotated Code of Maryland 20 
 (2021 Replacement Volume and 2022 Supplement) 21 
 
BY repealing and reenacting, with amendments, 22 
 Article – Health Occupations 23  2 	SENATE BILL 647  
 
 
Section 12–101(g), 12–202(a) and (b), 12–6B–06, and 12–802 1 
 Annotated Code of Maryland 2 
 (2021 Replacement Volume and 2022 Supplement) 3 
 
BY adding to 4 
 Article – Health Occupations 5 
Section 12–307(e) 6 
 Annotated Code of Maryland 7 
 (2021 Replacement Volume and 2022 Supplement) 8 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 9 
That the Laws of Maryland read as follows: 10 
 
Article – Health Occupations 11 
 
12–101. 12 
 
 (a) In this title the following words have the meanings indicated. 13 
 
 (g) (1) “Delegated pharmacy act” means an activity that constitutes the 14 
practice of pharmacy delegated by a licensed pharmacist under this title and regulations 15 
adopted by the Board. 16 
 
 (2) “Delegated pharmacy act” does not include: 17 
 
 (i) An act within the parameters of a therapy management 18 
contract as provided under Subtitle 6A of this title; 19 
 
 [(ii) The EXCEPT AS PROVIDED IN § 12–6B–06 OF THIS TITLE, 20 
THE administration of an influenza A vaccination in accordance with § 12–508 of this 21 
title;] 22 
 
 [(iii)] (II) The delegation of a pharmacy act by a registered 23 
pharmacy technician, pharmacy student, or pharmacy technician trainee; 24 
 
 [(iv)] (III) A pharmacy activity performed by a pharmacy student in 25 
accordance with § 12–301(b) of this title; 26 
 
 [(v)] (IV) A pharmacy activity performed by an applicant for a 27 
license to practice pharmacy in accordance with regulations adopted by the Board; [or] 28 
 
 (V) (VI) A DECISION–MAKING TASK THAT REQ UIRES THE 29 
PROFESSIONAL JUDGMEN T OF A PHARMACIST ; AND 30 
 
 (vi) (VII) The performance of other functions prohibited in 31 
regulations adopted by the Board. 32   	SENATE BILL 647 	3 
 
 
 
12–202. 1 
 
 (a) (1) The Board consists of [twelve] 13 members. 2 
 
 (2) Of the [twelve] 13 Board members: 3 
 
 (i) Ten shall be licensed pharmacists, including: 4 
 
 1. Two who at the time of appointment practice primarily in 5 
chain store pharmacies; 6 
 
 2. Two who at the time of appointment practice primarily in 7 
independent pharmacies; 8 
 
 3. Two who at the time of appointment practice primarily in 9 
an acute–care hospital; 10 
 
 4. One who at the time of appointment practices primarily 11 
in a pharmacy that provides services to a long–term care facility; 12 
 
 5. One who at the time of appointment practices primarily 13 
in a pharmacy that specializes in the provision of home infusion/home care services; and 14 
 
 6. Two pharmacists at–large; [and] 15 
 
 (II) ONE SHALL BE A REGIST ERED PHARMACY TECHNI CIAN; 16 
AND 17 
 
 [(ii)] (III) Two shall be consumer members. 18 
 
 (3) (i) The Governor shall appoint the chain store pharmacist 19 
members, with the advice of the Secretary, from a list of names submitted to the 20 
Secretary and the Governor by the Maryland Association of Chain Drug Stores. 21 
 
 (ii) The Governor shall appoint the independent pharmacist 22 
members, with the advice of the Secretary, from a list of names submitted to the 23 
Secretary and the Governor by the Maryland Pharmacists Association and the Maryland 24 
Pharmaceutical Society. 25 
 
 (iii) The Governor shall appoint the acute–care hospital pharmacist 26 
members, with the advice of the Secretary, from a list of names submitted to the 27 
Secretary and the Governor by the Maryland Society of Health–System Pharmacists. 28 
 
 (iv) The Governor shall appoint the long –term care facility 29 
pharmacist member, with the advice of the Secretary, from a list of names submitted to 30  4 	SENATE BILL 647  
 
 
the Secretary and the Governor by the Maryland Chapter of the American Society of 1 
Consultant Pharmacists. 2 
 
 (v) The Governor shall appoint the home infusion/home care 3 
pharmacist member, with the advice of the Secretary, from a list of names submitted to 4 
the Secretary and the Governor by the Maryland Society of Health–System Pharmacists. 5 
 
 (vi) The Governor shall appoint the at–large pharmacist members, 6 
with the advice of the Secretary, from a list of all names submitted to the Maryland 7 
Pharmacists Association, and then forwarded to the Secretary and the Governor. 8 
 
 (VII) THE GOVERNOR SHALL APPOIN T THE REGISTERED 9 
PHARMACY TECHNICIAN MEMBER, WITH THE ADVICE OF T HE SECRETARY, FROM A 10 
LIST OF ALL NAMES SU BMITTED TO THE SECRETARY AND THE GOVERNOR BY THE 11 
MARYLAND SOCIETY OF HEALTH–SYSTEM PHARMACISTS AND THE MARYLAND 12 
PHARMACISTS ASSOCIATION. 13 
 
 [(vii)] (VIII) Except for the at–large vacancies, the number of names 14 
on each list submitted to the Secretary and the Governor under this paragraph shall be 15 
three times the number of vacancies. 16 
 
 (4) For each pharmacist vacancy AND EACH REGISTERED PHARMACY 17 
TECHNICIAN VACANCY : 18 
 
 (i) The Board shall notify all licensed pharmacists, REGISTERED 19 
PHARMACY TECHNICIANS , and other interested parties of record in the State of the 20 
vacancy to solicit nominations to fill the vacancy and provide information for contacting a 21 
representative of the group that submits the list of names to the Governor under 22 
paragraph (3) of this subsection; and 23 
 
 (ii) Except for the at–large vacancies, each association that is 24 
responsible for submitting a list of nominees to the Secretary and the Governor under this 25 
section shall: 26 
 
 1. Issue a nomination form upon the request of any licensed 27 
pharmacist and consider all nominations received by the association’s deadline; 28 
 
 2. Form a committee, which recognizes diversity within the 29 
State in geographic distribution, sex, race, and age, comprised of at least five pharmacists 30 
to review nominations, interview all qualified nominees in a meeting open to the public, 31 
and select three names for each vacancy to be submitted to the Secretary and the 32 
Governor; and 33 
 
 3. In the event that fewer than three qualified nominees are 34 
submitted to the association, select any additional names that are needed to complete the 35 
list required to be submitted to the Secretary and the Governor under this section. 36   	SENATE BILL 647 	5 
 
 
 
 (5) The Governor shall appoint the consumer members with the advice of 1 
the Secretary and the advice and consent of the Senate. 2 
 
 (6) Each member of the Board shall be a resident of this State. 3 
 
 (7) A member of the Board shall be recused from all aspects of the 4 
licensing exam if that Board member: 5 
 
 (i) Is a member of the board of trustees at a school of pharmacy; 6 
 
 (ii) Is a teacher at a school of pharmacy; or 7 
 
 (iii) Acquires the member’s primary source of income through 8 
employment by a school of pharmacy. 9 
 
 (b) Each pharmacist member AND EACH REGISTERED 	PHARMACY 10 
TECHNICIAN MEMBER of the Board shall: 11 
 
 (1) Be skilled and competent in practicing pharmacy; and 12 
 
 (2) Have at least 5 years of active pharmacy practice. 13 
 
12–307. 14 
 
 (d) A licensed pharmacist may delegate pharmacy acts to a registered pharmacy 15 
technician, pharmacy student, or pharmacy technician trainee provided that ONLY IF the 16 
delegated pharmacy acts: 17 
 
 (1) Are directly supervised by a licensed pharmacist; 18 
 
 (2) Are not required to be performed by a licensed pharmacist; 19 
 
 (3) Are within the education, training, experience, and area of practice of 20 
the delegating licensed pharmacist; and 21 
 
 (4) Are appropriate to the education, training, and experience of the 22 
registered pharmacy technician, pharmacy student, or pharmacy technician trainee. 23 
 
 (E) A LICENSED PHARMACIST MAY DELEGATE PHARMACY ACTS , 24 
INCLUDING THE ENTERING ENTRY OF PRESCRIPTION–RELATED DATA INTO 25 
DATABASES OR PATIENT CHARTS, TO BE PERFORMED AT A REMOTE LOCATION TO A 26 
REGISTERED PHARMACY TECHNICIAN OR A REGI STERED PHARMACY INTE RN 27 
PROVIDED THAT THE DE LEGATED PHARMACY ACT S IF: 28 
 
 (1) ARE SUPERVISED BY A L ICENSED PHARMACIST ; 29  6 	SENATE BILL 647  
 
 
 
 (1) THE REGISTERED PHARMA CY TECHNICIAN OR REG ISTERED 1 
PHARMACY INTERN HAS IMMEDIATE ELECTRONIC ACCESS TO A PHARMACI ST WHO 2 
CAN PROVIDE ASSISTAN CE AS NEEDED; AND 3 
 
 (2) THE DATA ENTRY : 4 
 
 (2) (I) ARE IS NOT REQUIRED TO BE P ERFORMED BY A LICENS ED 5 
PHARMACIST ; 6 
 
 (3) DO NOT INVOLVE THE CO MPOUNDING , DISTRIBUTION, OR 7 
DISPENSING OF PRESCR IPTION OR NONPRESCRI PTION DRUGS; 8 
 
 (4) (II) ARE IS WITHIN THE EDUCATION , TRAINING, EXPERIENCE, 9 
AND AREA OF PRACTICE OF THE DELEGATING LI CENSED PHARMACIST ;  10 
 
 (5) (III) ARE IS APPROPRIATE TO THE E DUCATION, TRAINING, AND 11 
EXPERIENCE OF THE RE GISTERED PHARMACY TE CHNICIAN OR THE REGI STERED 12 
PHARMACY INTERN ; AND  13 
 
 (6) (IV) IF THE DELEGATED ACT DATA ENTRY INVOLVES ACCESS TO 14 
PROTECTED PATIENT IN FORMATION UNDER THE FEDERAL HEALTH INSURANCE 15 
PORTABILITY AND ACCOUNTABILITY ACT OF 1996, CAN BE PERFORMED IN A 16 
MANNER THAT MAINTAIN S THE CONFIDENTIALIT Y OF PATIENT INFORMA TION. 17 
 
12–6B–06. 18 
 
 (a) Registration authorizes a registered [pharmacist] PHARMACY technician to 19 
perform delegated pharmacy acts as defined in § 12–101 of this title while the registration 20 
is effective. 21 
 
 (b) A registered pharmacy technician or a pharmacy technician trainee may not: 22 
 
 (1) Act within the parameters of a therapy manageme nt contract as 23 
provided under Subtitle 6A of this title; 24 
 
 (2) [Administer an influenza vaccination in accordance with § 12–508 of 25 
this title] MAKE DECISIONS THAT R EQUIRE THE PROFESSIO NAL JUDGMENT OF A 26 
PHARMACIST ; 27 
 
 (3) Delegate a pharmacy act that was d elegated to the registered 28 
pharmacy technician or individual engaging in a Board approved technician training 29 
program; or 30 
   	SENATE BILL 647 	7 
 
 
 (4) Perform other functions prohibited by regulations adopted by the 1 
Board. 2 
 
 (C) (1) A REGISTERED PHARMACY TECHNICIAN MAY ADMIN ISTER, IN 3 
ACCORDANCE WITH § 12–508 OF THIS TITLE:  4 
 
 (I) AN INFLUENZA, COVID–19, OR PNEUMONIA VACCINA TION 5 
TO AN INDIVIDUAL AT LEAST 18 YEARS OLD; AND 6 
 
 (II) A RESPIRATORY SYNCYTIA L VIRUS OR SHINGLES 7 
VACCINATION TO AN IN DIVIDUAL AT LEAST 50 YEARS OLD. 8 
 
 (2) EXCEPT AS PROVIDED IN PARAGRAPH (1) OF THIS SUBSECTION , 9 
A REGISTERED PHARMAC Y TECHNICIAN MAY NOT ADMINISTER A VACCINA TION IN 10 
ACCORDANCE WITH § 12–508 OF THIS TITLE. 11 
 
 (D) A PHARMACY TECHNICIAN TRAINEE MAY NOT ADMI NISTER A 12 
VACCINATION IN ACCOR DANCE WITH § 12–508 OF THIS TITLE. 13 
 
12–802. 14 
 
 Subject to the evaluation and reestablishment provisions of the Program 15 
Evaluation Act, this title and all rules and regulations adopted under this title shall 16 
terminate and be of no effect after July 1, [2023] 2033 2025. 17 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 18 
October 1, 2023.  19 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act is an emergency 20 
measure, is necessary for the immediate preservation of the public health or safety, has 21 
been passed by a yea and nay vote supported by three–fifths of all the members elected to 22 
each of the two Houses of the General Assembly, and shall take effect from the date it is 23 
enacted.  24 
 
 
 
 
Approved: 
________________________________________________________________________________  
 Governor. 
________________________________________________________________________________  
         President of the Senate. 
________________________________________________________________________________  
  Speaker of the House of Delegates.